St. John’s University Pharmaceutical Industry Fellowship 2027, USA
The St. John’s University College of Pharmacy and Health Sciences is inviting applications from prospective candidates around the world for its prestigious Pharmaceutical Industry Fellowship Programs. Designed for recent Doctor of Pharmacy (Pharm.D.) graduates, this two-year post-doctoral opportunity offers advanced training in specialized pharmaceutical fields, bridging academic research with industry-focused professional development in the United States.
Designation
Position Title: Post-Pharm.D. Fellow / Pharmaceutical Industry Fellow
Program Details Table
| Feature | Details |
|---|---|
| Host Institution | St. John’s University (College of Pharmacy and Health Sciences) |
| Program Level | Post-Pharm.D. (Two-Year Postdoctoral Fellowship) |
| Funding Coverage | Funded |
| Eligible Candidates | All Nationalities (International and Domestic Applicants) |
| Country | United States |
| Primary Application Deadline | October 23, 2026 |
Research Area & Industry Focus
St. John’s University collaborates with top-tier pharmaceutical companies to offer targeted fellowship positions across several key practice and research areas:
- Medical Affairs: Partnered with American Regent, Inc. (1 position)
- Health Economics and Outcomes Research (HEOR) & Global Market Access: Partnered with Pfizer Inc. (1 position)
- Clinical Development: Partnered with Allergan Aesthetics, an AbbVie Company (1 position)
- Global Regulatory Affairs: Partnered with PTC Therapeutics (1 position)
Location
The fellowship is based in the United States. Fellows work directly with institutional and corporate facilities while actively engaging in academic activities, research, and teaching at St. John’s University in New York.
Eligibility / Qualification
To be eligible for the St. John’s University Pharmaceutical Industry Fellowship 2027, candidates must fulfill the following requirements:
- Educational Background: Applicants must hold or be on track to complete a Doctor of Pharmacy (Pharm.D.) degree prior to the start of the fellowship.
- Nationality: Open to all international candidates as well as U.S. citizens and permanent residents.
- Professional Competence: A strong commitment to research, teaching, and specialized clinical practice within the pharmaceutical sector.
Scholarship Description
The Pharmaceutical Industry Fellowship at St. John’s University provides a comprehensive two-year postdoctoral experience combining hands-on industry expertise with academic development. Established in 1870, St. John’s University is a member of the Alliance of Industry Fellowship Associates (AIFA), adhering to a fair and standardized admissions process. Fellows gain valuable experience by lecturing and conducting research at the university while contributing to critical industry projects alongside global pharmaceutical partners. The program follows AIFA-aligned offer standards, providing applicants adequate time to assess options.
How to Apply
Interested candidates must follow the formal application steps to be considered for an interview:
- Prepare a updated Curriculum Vitae (CV) and a tailored Letter of Intent (LOI) for each position of interest. Candidates applying to multiple positions must submit distinct LOIs for each specific program.
- Email your application materials directly to the St. John’s University fellowship leadership team at stjfellowships@stjohns.edu.
- Participate in rolling virtual programmatic interviews starting in October.
- Optional in-person interviews may be conducted during the ASHP Midyear Clinical Meeting if mutually agreed upon by candidates and partner companies.
For official details and complete application guidelines, visit the official portal: St. John’s University Fellowship Program Page.
Last Date for Apply
Applicants must adhere strictly to the following submission deadlines:
- October 23, 2026: Deadline for Curriculum Vitae (CV) and Letter of Intent (LOI).
- October 27, 2026: Deadline for Official College Transcripts and Three Letters of Recommendation.
- December 12, 2026: AIFA-aligned first offer release date.